Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001415889-23-000289

Options or other derivatives

  • PRESIDENT AND HEAD OF R&D acquired 136,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huber Martin H. Jr. · PRESIDENT AND HEAD OF R&D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-01 Grant or award : show line 1 in the form Stock Option (right to buy) +136,500 136,500 D
Loading xslF345X03/form4-01042023_090139.xml…